Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDA_Drug_Info: #FDAs Clinical Safety and Surveillance Staff ensures the safety of generic drugs on the U.S. market.… https://t.co/NeEcqcgirM

While our approach to #artificialintelligence must be flexible to keep pace with its unique traits, it must establish appropriate guardrails for patients to meet our standards for safety and effectiveness and so we instill confidence in their benefits: ht

RT @StephCaccomo: Another #artificialintelligence authorization today: https://t.co/x7e3VZ2NF7 https://t.co/zayfsvrqKY QT @SGottliebFDA: Given the enormous promise of #artificialintelligence technologies for the future of medicine, our #digitalhealth t… https://t.co/lXFEU4v9ED)

Given the enormous promise of #artificialintelligence technologies for the future of medicine, our #digitalhealth team is actively developing a new regulatory framework to promote and support innovation in this this rapidly advancing field #FDAPrecert: ht

Large influx of new synthetic opioids permeating the street-drug market, including fentanyl, has generated the need for a fast, effective method to evaluate the risk a substance poses to public safety: https://t.co/jg3Grmom3L

#FDA’s work on scientific modeling, highlighted in @PLOS today, adds to the agency’s understanding of the level of risk certain opioid products can pose to consumers: https://t.co/jg3Grmom3L

New article published in @PLOS today discusses how #FDA researchers have developed a rapidly-deployable, multi-pronged computational approach to assess an opioid’s risk to public health: https://t.co/jg3Grmom3L

#FDA estimates in @NEJM show the potential public health impact of limiting nicotine in cigarettes https://t.co/I47uFMQPhF https://t.co/NSPitmvT5u

As part of our longstanding commitment to the development of medical countermeasures, #FDA takes new steps to modernize our guidance on the development of novel drugs for the prevention of inhalational anthrax https://t.co/321p4wU4Eu

#FDA’s approach to #artificialintelligence must be flexible to keep pace with its unique traits, and it must also establish appropriate guardrails for patients - to meet our standards for safety and effectiveness - so we instill confidence in these tools:

We recognize the tremendous promise of #artificialintelligence technologies for the future of medicine. Our #digitalhealth team is actively developing a new regulatory framework to promote and support innovation in this rapidly advancing field #FDAPrecert

RT @FDAWomen: #Pain medication - learn how to use it safely: https://t.co/g9d565VLVw

I recently outlined some of the comprehensive steps #FDA is taking to advance digital health technologies broadly. We’ll have more to say on this at ASCO and will make some significant, new announcements throughout the summer as we build out our programs

@daviesbj @adamfeuerstein Vegetarians don’t eat potato salad?

Thanks for your focus on food safety @adamfeuerstein - This isn’t actually something I’ve specifically addressed; but since you mention it, you can find some BBQ tips here https://t.co/oykCOO2Io6.  Note food can be left outside for 2 hours; one hour if te QT @adamfeuerstein: Also… Don’t leave your mayo-based potato salad out in the sun during the family cookout, advises @SGottliebFDA https://t.co/ptL1LJqHXy)

It’s the season for picnics and cookouts but eating outdoors in warm weather presents a food safety challenge. Bacteria in food multiply faster in warmer temps, so summer heat makes the basics of food safety especially important. https://t.co/o5JYSpugpT h

RT @AtlanticLIVE: What We’re Watching: @SGottliebFDA joins @SCClemons to discuss the impacts of competitive pricing of prescription d… https://t.co/3xi92T7fFS

We appreciate the funding increase approved yesterday by Senate Appropriations Committee. These resources will help advance key #FDA priorities including working with Congress to combat opioid abuse and improve medical product and food safety https://t.co

RT @WHOSTP: Artificial intelligence can help our best doctors perform even better. @US_FDA approvals now include AI tools to help spot wris… QT @SGottliebFDA: We recognize the tremendous promise of #artificialintelligence technologies for the future of medicine. Our… https://t.co/oQULXWQERP)

RT @FDAOncology: Tissue agnostic approval: Is it different from regular approval? #FDAOncology's Steven Lemery to discuss at #ASCO18… https://t.co/eSDNxrzqMv

RT @FDA_Drug_Info: #FDAs Clinical Safety and Surveillance Staff ensures the safety of generic drugs on the U.S. market.… https://t.co/NeEcqcgirM

While our approach to #artificialintelligence must be flexible to keep pace with its unique traits, it must establish appropriate guardrails for patients to meet our standards for safety and effectiveness and so we instill confidence in their benefits: ht

RT @StephCaccomo: Another #artificialintelligence authorization today: https://t.co/x7e3VZ2NF7 https://t.co/zayfsvrqKY QT @SGottliebFDA: Given the enormous promise of #artificialintelligence technologies for the future of medicine, our #digitalhealth t… https://t.co/lXFEU4v9ED)

Given the enormous promise of #artificialintelligence technologies for the future of medicine, our #digitalhealth team is actively developing a new regulatory framework to promote and support innovation in this this rapidly advancing field #FDAPrecert: ht

Large influx of new synthetic opioids permeating the street-drug market, including fentanyl, has generated the need for a fast, effective method to evaluate the risk a substance poses to public safety: https://t.co/jg3Grmom3L

#FDA’s work on scientific modeling, highlighted in @PLOS today, adds to the agency’s understanding of the level of risk certain opioid products can pose to consumers: https://t.co/jg3Grmom3L

New article published in @PLOS today discusses how #FDA researchers have developed a rapidly-deployable, multi-pronged computational approach to assess an opioid’s risk to public health: https://t.co/jg3Grmom3L

#FDA estimates in @NEJM show the potential public health impact of limiting nicotine in cigarettes https://t.co/I47uFMQPhF https://t.co/NSPitmvT5u

As part of our longstanding commitment to the development of medical countermeasures, #FDA takes new steps to modernize our guidance on the development of novel drugs for the prevention of inhalational anthrax https://t.co/321p4wU4Eu

#FDA’s approach to #artificialintelligence must be flexible to keep pace with its unique traits, and it must also establish appropriate guardrails for patients - to meet our standards for safety and effectiveness - so we instill confidence in these tools:

We recognize the tremendous promise of #artificialintelligence technologies for the future of medicine. Our #digitalhealth team is actively developing a new regulatory framework to promote and support innovation in this rapidly advancing field #FDAPrecert

RT @FDAWomen: #Pain medication - learn how to use it safely: https://t.co/g9d565VLVw

I recently outlined some of the comprehensive steps #FDA is taking to advance digital health technologies broadly. We’ll have more to say on this at ASCO and will make some significant, new announcements throughout the summer as we build out our programs

@daviesbj @adamfeuerstein Vegetarians don’t eat potato salad?

Thanks for your focus on food safety @adamfeuerstein - This isn’t actually something I’ve specifically addressed; but since you mention it, you can find some BBQ tips here https://t.co/oykCOO2Io6.  Note food can be left outside for 2 hours; one hour if te QT @adamfeuerstein: Also… Don’t leave your mayo-based potato salad out in the sun during the family cookout, advises @SGottliebFDA https://t.co/ptL1LJqHXy)

It’s the season for picnics and cookouts but eating outdoors in warm weather presents a food safety challenge. Bacteria in food multiply faster in warmer temps, so summer heat makes the basics of food safety especially important. https://t.co/o5JYSpugpT h

RT @AtlanticLIVE: What We’re Watching: @SGottliebFDA joins @SCClemons to discuss the impacts of competitive pricing of prescription d… https://t.co/3xi92T7fFS

We appreciate the funding increase approved yesterday by Senate Appropriations Committee. These resources will help advance key #FDA priorities including working with Congress to combat opioid abuse and improve medical product and food safety https://t.co

RT @WHOSTP: Artificial intelligence can help our best doctors perform even better. @US_FDA approvals now include AI tools to help spot wris… QT @SGottliebFDA: We recognize the tremendous promise of #artificialintelligence technologies for the future of medicine. Our… https://t.co/oQULXWQERP)

RT @FDAOncology: Tissue agnostic approval: Is it different from regular approval? #FDAOncology's Steven Lemery to discuss at #ASCO18… https://t.co/eSDNxrzqMv